Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL63732 | 0.81 | GAA (0.33) | GAA | |
| SCHEMBL64553 | 0.71 | LMNA (0.36) | LMNAKDM4ETDP1 | |
| SCHEMBL6941430 | 0.69 | — | — | |
| SCHEMBL11956551 | 0.67 | IDO1 (0.33) | LMNAKDM4EGAA | |
| SCHEMBL8432933 | 0.66 | KDM4E (0.36) | LMNAKDM4E | |
| SCHEMBL28180625 | 0.64 | — | — | |
| SCHEMBL24775834 | 0.64 | CA1 (0.33) | LMNAKDM4E | |
| Trifluoromethanesulfonic Acid SCHEMBL9065588 | 0.63 | KCNH2 (0.43) | GAAGPR3 | |
| SCHEMBL28205938 | 0.61 | CA2 (0.38) | KDM4EALDH1A1 | |
| SCHEMBL28285273 | 0.60 | HDAC8 (0.36) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8558012-B2 | 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same | NAGOYA INSTITUTE OF TECHNOLOGY (JP) | 2013-10-15 | — | — | US | claimed |
| JP-5294937-A | — | — | None | — | — | JP | disclosed |
| US-8558012-B2 | 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same | NAGOYA INSTITUTE OF TECHNOLOGY (JP) | 2013-10-15 | — | — | US | disclosed |
| US-8207184-B2 | Condensation compound between fluorinated cyclopentane ring and aromatic ring, and process for producing the same | SUMITOMO CHEMICAL CO., LTD. (JP) | 2012-06-26 | — | — | US | disclosed |
| US-8129400-B2 | Condensation compound between fluorinated cyclopentane ring and aromatic ring, and process for producing the same | SUMITOMO CHEMICAL CO., LTD. (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20110319637-A1 | 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME | NAGOYA INSTITUTE OF TECHNOLOGY (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20110282073-A1 | CONDENSATION COMPOUND BETWEEN FLUORINATED CYCLOPENTANE RING AND AROMATIC RING, AND PROCESS FOR PRODUCING THE SAME | SUMITOMO CHEMICAL CO., LTD. (JP) | 2011-11-17 | — | — | US | disclosed |
| US-20110213162-A1 | CONDENSATION COMPOUND BETWEEN FLUORINATED CYCLOPENTANE RING AND AROMATIC RING, AND PROCESS FOR PRODUCING THE SAME | SUMITOMO CHEMICAL CO., LTD. (JP) | 2011-09-01 | — | — | US | disclosed |
| US-8008336-B2 | Forming electronic material, semiconductors | SUMITOMO CHEMICAL CO., LTD. (JP) | 2011-08-30 | — | — | US | disclosed |
| US-7638654-B2 | 1-fluoro-1, 1-bis-(phenylsulfonyl)methane and production method thereof | NAGOYA INSTITUTE OF TECHNOLOGY (JP) | 2009-12-29 | — | — | US | disclosed |
| US-5945438-A | ANTIMYCOTIC AGENT | SS PHARMACEUTICAL CO., LTD. (JP) | 1999-08-31 | — | — | US | disclosed |
| US-5939448-A | ANTIMYCOTIC AGENT | SS PHARMACEUTICAL CO., LTD. (JP) | 1999-08-17 | — | — | US | disclosed |
| EP-0933368-A1 | Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient (antimycotic) | SSP Co., Ltd. (JP) | 1999-08-04 | — | — | EP | disclosed |
| EP-0927719-A1 | Triazole derivative or salt thereof, preparation process thereof as well as pharmaceutical containing said compound | SSP Co., Ltd. (JP) | 1999-07-07 | — | — | EP | disclosed |
| EP-0899265-A1 | Triazole derivatives and their use as antimycotic agents | SSP Co., Ltd. (JP) | 1999-03-03 | — | — | EP | disclosed |
| EP-0814079-A1 | Triazole derivative or salt thereof | SS PHARMACEUTICAL CO., LTD. (JP) | 1997-12-29 | — | — | EP | disclosed |
| EP-0780380-A1 | Triazole derivatives with antimycotic action and intermediates | SS PHARMACEUTICAL CO., LTD. (JP) | 1997-06-25 | — | — | EP | disclosed |
| US-5374732-A | Chemical intermediates as fluorination agents | DAIKIN INDUSTRIES, LTD. (JP) | 1994-12-20 | — | — | US | disclosed |
| JP-H05294937-A | NEW SUBSTITUTED N-FLUOROPYRIDINIUM SULFONATE, ITS PRODUCTION INTERMEDIATE AND THEIR PRODUCTION | DAIKIN IND LTD | 1993-11-09 | — | — | JP | disclosed |
| EP-0526849-A1 | Novel substituted N-Fluoropyridiniumsulfonate, intermediates therefor and preparation processes thereof | DAIKIN INDUSTRIES, LTD. (JP) | 1993-02-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319637-A1 | 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME | CBR1, CYP1B1, CYP2F1 | LMNA 3752/4885KDM4E 3266/4885TDP1 1635/4885 |
| US-20110213162-A1 | CONDENSATION COMPOUND BETWEEN FLUORINATED CYCLOPENTANE RING AND AROMATIC RING, AND PROCESS FOR PRODUCING THE SAME | RCC1, AFF4, TPR | LMNA 3489/4885KDM4E 1633/4885TDP1 2969/4885 |
| US-20110282073-A1 | CONDENSATION COMPOUND BETWEEN FLUORINATED CYCLOPENTANE RING AND AROMATIC RING, AND PROCESS FOR PRODUCING THE SAME | RCC1, AFF4, TPR | LMNA 3489/4885KDM4E 1633/4885TDP1 2969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.